Latest news
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings? - The Motley FoolThe Motley Fool · Mon, 10 Aug 2026 14:18:05 GMTAbbVie Stock After the Apogee Financing: What $10 Billion in Notes Signals. - TIKR.comTIKR.com · Mon, 10 Aug 2026 11:18:54 GMTAbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeatMarketBeat · Mon, 10 Aug 2026 06:49:33 GMTAbbVie Inc. (ABBVD.BA) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Sun, 09 Aug 2026 10:16:15 GMTAbbVie Inc. (ABBV) Stock forecasts - Yahoo Finance SingaporeYahoo Finance Singapore · Sat, 08 Aug 2026 13:53:33 GMTAbbVie (ABBV) Stock May Be 45% Below Fair Value As Rinvoq Expands In Europe - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:46:03 GMTAbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 21:24:00 GMTAbbVie to Acquire Apogee Therapeutics for $10.9 Billion, Gaining IL-13 Antibody Zumilokibart - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMT